Si~t~ltTlcily
Serum levels of keratan sulphate (KS) were found to be significantly elevated in patients with destructive and predominantly seronegative rheumatoid arthritis (RA) compared with a control population. Levels in RA did not correlate with clinical or laboratory indices of joint activity or damagc. Convcrsely levels were depressed in ankylosing spondylitis (AS) compared with controls.
Ititrodirctiori
KS is a glycosaminoglycan which quantitatively is almost entirely confined t o hyaline cartilage. Serum levels rise in cartilage breakdown and may be a useful marker of cartilage turnover in rheumatic conditions [ 11.
Methods

I'atietit selectiori.
Out-patients with RA and AS who werc being assessed in clinical and radiological studies had serum stored at -70°C for measurement of the KS level. Serum was also collected from adult controls who denied a history of joint disease.
2. C'litiitd u.s.ses.smetit. In the RA study, data were collected o n the level of joint pain and stiffness, the number of swollen and tender joints (Ritchie index), the hand functional index (HFI), a component of the Keitel function test (KFT) [ 2 ] , the range of joint movement and the Stanford health assessment questionaire (HAQ). A score for the degree of joint damage (DS) was derived depending upon the loss of joint movement (score 0-20). In the AS group, data were obtained for the degree of spinal pain, stiffness and loss o f movement and the level of peripheral joint inflammation (swelling and increased warmth) and damage (loss of joint movement).
3. Lrihonrtot? (r.s.s~~.s.stti~'tit. The C-reactive protein (CRP) lcvcl was measured in all patients and the rheumatoid factor titrc in PA patients. Serial determinations of KS gave reproducible results and freezing/thawing of the sample four to five times did not influence the KS level. The mean KS level in the RA patients was significantly increased cornpared with the controls (1'<0.001) (Fig. 1). 2. Atikylositig spondylitis. The AS patients (24 male, 6 female) had a mean age of 43.8 f 10.3 years and a mean disease duration of 23.8 f 9.8 years. The serum KS level was significantly depressed in the AS patients compared with the controls (P<0.001) (Fig. 1) . 
(.or ichrsiot i s
Serum levels of KS were significantly elevated in this cross-sectional study of predominantly seronegative RA compared with young healthy controls, but did not correlate with measures of current joint activity or indices of joint damage. Destructive or erosive disease of the hands or wrists was an entry criteria for the RA study, but in some of these patients destructive joint disease may have developed many years previously and the serum KS level at the time of the clinical assessment is unlikely to correlate with the degree of joint damage. Conversely, other patients with markedly elevated serum KS levels were likely to be actively resorbing cartilage at the time of the study. Serum levels of KS do not only reflect increased cartilagc breakdown. but may also reflect increased proteoglycan synthesis.
Clinical instruments for identifying patients who are actively destroying their cartilage are not currently available. The relationship between serum KS levels and measures of progressive joint damage can probably only be adequately assessed in a prospective study where the rate of progressive joint damage can be measured radiographically.
The low serum KS levels in AS patients are surprising and may reflect depressed cartilage turnover in these patients or cleavage of KS peptide fragments in the joint or in the circulation. Recent work has demonstrated that the SD4 antibody has a greater avidity for larger KS fragments than smaller ones 141. An unlikely possibility to explain the findings is a primary modification of the KS epitope recognized by SD4 in AS.
